纳米颗粒作为非病毒载体的进步,可以有效地传递CRISPR/Cas9

Minse Kim1,2, Youngwoo Hwang2,3, Seongyu Lim1,2

  • 1Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic of Korea.

Pharmaceutics
|September 28, 2024
PubMed
概括

非病毒纳米粒子为提供CRISPR/Cas9基因编辑技术提供了有希望的替代方案,克服了潜在临床应用和基因治疗的病毒载体的局限性.